Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Polymorphonuclear Cells in the Middle Turbinate

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity Hospital, Montpellier

About this trial

This monocentric, interventional study (category RIPH2) aims to characterize the rheological properties of sinonasal secretions in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). The primary objective is to determine differences in mucus viscosity between CRSwNP patients and a control group. By establishing a correlation between local rheology and systemic Type 2 inflammation biomarkers, the study seeks to develop a non-invasive, rapid "point-of-care" tool to refine patient phenotyping and improve the personalization of biological treatments.

Eligibility criteria

Qualifiers

Patient requiring sinonasal surgery

Nasal congestion

Rhinorrhea (anterior/posterior)

Or a Facial pain/pressure

Disqualifiers

Inability to provide a sinonasal secretion sample by blowing

Conditions causing secondary nasal polyposis (e.g., cystic fibrosis, ciliary dyskinesia, immune disorders, allergic fungal sinusitis)

Illiteracy

Lack of consent

Trial design

Treatments tested in this trial

  • Sinonasal sample collection and inflammatory assessment

Treatment groups

60 Participants
are divided into 1 treatment group